Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer
NCT03015298 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-01-10
Summary
The results of PET/MRI and PET/CT in each recruited gastric cancer patients will be compared.
Conditions
- Gastric Cancer Stage
Interventions
- DEVICE
-
PET/MRI
The recruited patients will receive a PET/MRI examination to evaluation the stage and resectability of the cancer.
- DEVICE
-
PET/CT
At the next day of PET/MRI examination,A PET/CT examination will be performed.
Sponsors & Collaborators
-
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
Jianxin Cui, Doctor · the Chinese PLA General Hospital
-
Yi Liu · the Chinese PLA General Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-06-30
More Related Trials
-
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
NCT05430841 ·Status: COMPLETED ·Phase: NA
-
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126 ·Status: RECRUITING
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694 ·Status: RECRUITING
-
Study of CT and MR in the Gastric Cancer
NCT04028375 ·Status: UNKNOWN
-
The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer
NCT06327386 ·Status: RECRUITING
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
NCT06182644 ·Status: RECRUITING ·Phase: NA
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of 99mTc-FAPI SPECT/CT and 68Ga-FAPI PET/CT
NCT05444686 ·Status: UNKNOWN ·Phase: NA
-
Comparison of FDG and FAPI in Patients With Various Types of Cancer
NCT04416165 ·Status: RECRUITING ·Phase: NA
-
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
NCT03288597 ·Status: UNKNOWN
-
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy
NCT04913896 ·Status: UNKNOWN
-
Standard PET/CT vs. Digital PET/CT
NCT03081767 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814 ·Status: RECRUITING
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
NCT04883970 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
NCT06644274 ·Status: RECRUITING
-
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer
NCT04831541 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA